|
|
Conditions Treatable by Stem Cell Transplantation
This is a chart taken from Dr. David Steenblock’s excellent
website on stem cell therapy, www.stemcelltherapies.org
Diseases Treatable by Stem Cell Transplantation
Compilation from The National Donor Program, 2002 and www.stemcelltherapies.org, 2004
|
Stem Cell Disorders
Aplastic Anemia (Severe)
Fanconi Anemia
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Acute Leukemias
Acute Lymphoblastic Leukemia (ALL)
Acute Myelogenous Leukemia (AML)
Acute Biphenotypic Leukemia
Acute Undifferentiated Leukemia
Chronic Leukemias
Chronic Myelogenous Leukemia ( CML)
Chronic Lymphocytic Leukemia (CLL)
Juvenile Chronic Myelogenous Leukemia (JCML)
Junveile Myelomonocytic Leukemia (JMML)
Myeloproliferative Disorders
Acute Myelofibrosis
Agnogenic Myeloid Metaplasia
(myelofibrosis)
Polycythemia Vera
Essential Thrombocythemia
Myelodysplastic Syndromes
Refractory Anemia (RA)
Refractory Anemia with Ringed Sideroblasts (RARS)
Refractory Anemia with Excess Blasts (RAEB)
Refractory Anemia with Excess Blasts in Transformation (RAEB-T)
Chronic Myelomonocytic Leukemia (CMML)
Lymphoproliferative Disorders
Non-Hodgkin's Lymphoma
Hodgkin's Disease
Prolymphocytic Leukemia
Inherited Erythrocyte Abnormalities
Beta Thalassemia Major
Pure Red Cell Aplasia
Sickle Cell Disease |
Liposomal Storage Diseases
Mucopolysaccharidoses (MPS)
Hurler's Syndrome (MPS-IH)
Scheie Syndrome (MPS-IS)
Hunter's Syndrome (MPS-II)
Sanfilippo Syndrome (MPS-III)
Morquio Syndrome (MPS-IV)
Maroteaux-Lamy Syndrome (MPS-VI)
Sly Syndrome, Beta-Glucuronidase Deficiency (MPS-VII)
Adrenoleukodystrophy
Mucolipidosis II (I-cell Disease)
Krabbe Disease
Gaucher's Disease
Niemann-Pick Disease
Wolman Disease
Metachromatic Leukodystrophy
Histiocytic Disorders
Familial Erythrophagocytic Lymphohistiocytosis
Histiocytosis-X
Hemophagocytosis
Phagocyte Disorders
Chediak-Higashi Syndrome
Chronic Granulomatous Disease
Neutrophil Actin Deficiency
Reticular Dysgenesis
Inherited Platelet Abnormalities
Amegakaryocytosis/Congenital
Thrombocytopenia
Plasma Cell Disorders
Multiple Myeloma
Plasma Cell Leukemia
Waldenstrom's Macroglobulinemia
Other Malignancies
Breast Cancer
Ewing Sarcoma
Neuroblastoma
Renal Cell Carcinoma
Lung Disorders
COPD
Bronchial Asthma |
Congenital Immune System Disorders
Ataxia-Telangiectasia
Kostmann Syndrome
Leukocyte Adhesion Deficiency
DiGeorge Syndrome
Bare Lymphocyte Syndrome
Omenn's Syndrome
Severe Combined Immunodeficiency (SCID)
SCID with Adenosine Deaminase Deficiency
Absence of T & B Cells SCID
Absence of T Cells, Normal B Cell SCID
Common Variable Immunodeficiency
X-Linked Lymphoproliferative Disorder
Other Inherited Disorders
Lesch-Myhan Syndrome
Cartilage-Hair Hypoplasia
Glanzmann Thrombasthemia
Osteopetrosis
Neurological Conditions
Acute and Chronic Stroke
Traumatic Brain Injury
Cerebral Palsy
Multiple Sclerosis
Amyotrophic lateral sclerosis (ALS)
Autism
Cognitive Dysfunction
Epilepsy
Depression
Heart Conditions
Atherosclerosis
Congestive Heart Failure
Myocardial Infarction
Metabolic Disorders
Diabetes
Eye Disorders
Macular Degeneration
Optic Atrophy |
| |
Stem Cells Treatable Conditions-Alphabetical Listing
Diseases Treatable by Stem Cell Transplantation, Alphabetically
Compilation from The National Donor Program, 2002 and www.stemcelltherapies.org, 2004 |
Absence of T & B Cells SCID
Absence of T Cells, Normal B Cell SCID
Acute Biphenotypic Leukemia
Acute Lymphoblastic Leukemia (ALL)
Acute Myelofibrosis
Acute Myelogenous Leukemia (AML)
Acute Undifferentiated Leukemia
Adrenoleukodystrophy
Agnogenic Myeloid Metaplasia (myelofibrosis)
Alzheimer
Amegakaryocytosis/Congenital
Thrombocytopenia
Aplastic Anemia (Severe)
Amyotrophic lateral sclerosis (ALS)
Ataxia-Telangiectasia
Atherosclerosis
Autism
Bare Lymphocyte Syndrome
Beta Thalassemia Major
Breast Cancer
Bronchial Asthma
Cartilage-Hair Hypoplasia
Cerebral Palsy
Chediak-Higashi Syndrome
Chronic Granulomatous Disease
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelogenous Leukemia (CML)
Chronic Myelomonocytic Leukemia
(CMML)
Cognitive Dysfunction
Common Variable Immunodeficiency
Congestive Heart Failure
COPD
Depression
Diabetes
DiGeorge Syndrome |
Essential Thrombocythemia
Epilepsy
Ewing Sarcoma
Familial Erythrophagocytic Lymphohistiocytosis
Fanconi Anemia
Gaucher's Disease
Glanzmann Thrombasthemia
Histiocytosis-X
Hemophagocytosis
Hodgkin's Disease
Hunter's Syndrome (MPS-II)
Hurler's Syndrome (MPS-IH)
Juvenile Chronic Myelogenous Junveile
Kostmann Syndrome
Krabbe Disease
Lesch-Myhan Syndrome
Leukocyte Adhesion Deficiency
Macular Degeneration
Maroteaux-Lamy Syndrome (MPS-VI)
Metachromatic Leukodystrophy
Morquio Syndrome (MPS-IV)
Mucolipidosis II (I-cell Disease)
|
Mucopolysaccharidoses (MPS)
Multiple Myeloma
Multiple Sclerosis
Myelomonocytic Leukemia (JMML)
Myocardial Infarction
Niemann-Pick Disease
Neuroblastoma
Neutrophil Actin Deficiency
Non-Hodgkin's Lymphoma
Omenn's Syndrome
Optic Atrophy
Osteopetrosis
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Plasma Cell Leukemia
Polycythemia Vera
Prolymphocytic Leukemia
Pure Red Cell Aplasia
Refractory Anemia (RA)
Refractory Anemia with Ringed Sideroblasts (RARS)
Refractory Anemia with Excess Blasts (RAEB)
Refractory Anemia with Excess Blasts in Transformation (RAEB-T)
Renal Cell Carcinoma
Reticular Dysgenesis
Sanfilippo Syndrome (MPS-III)
Scheie Syndrome (MPS-IS)
SCID with Adenosine Deaminase Deficiency
Severe Combined Immunodeficiency (SCID)
Sickle Cell Disease
Sly Syndrome, Beta-Glucuronidase Deficiency (MPS-VII)
Stroke (acute and chronic)
Traumatic Brain Injury
Waldenstrom's Macroglobulinemia
Wolman Disease
X-Linked Lymphoproliferative Disorder |
|
The mesenchymal and umbilical cord blood stem cells used in this study are human cells, tissues, or cellular and tissue-based products (HCT/Ps) as defined in 21 CFR § 1271.3(d). Under 21 CFR Part 1271, HCT/Ps are not subject to licensure or IND requirements if certain criteria are met (21 CFR § 1271.10). These requirements include autologous use (use by the cell donor), or if used for other patients, the HCT/Ps must be “not more than minimally manipulated” and labeled for use for “homologous use only”. They may also not be used for a purpose requiring their “metabolic” activity.
StemLab S.A. mesenchymal and umbilical cord stem cells shipped to the United States of America have not been “more than minimally manipulated”. StemLab S.A. labels and intends its cells which are used within the United States of America only for homologous and non-metabolic purposes. StemLab S.A. does not interfere with the practice of medicine by individual physicians who use StemLab products, and who may do so according to their own medical training and informed choice.
|
